Guo-Yao Dai - Search Results

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2023	1
2025	1
2026	0

Page 1

MSN8C: A Promising Candidate for Antitumor Applications as a Novel Catalytic Inhibitor of Topoisomerase II.

Ou JB, Huang WH, Liu XZ, Dai GY, Wang L, Huang ZS, Huang SL. Ou JB, et al. Among authors: dai gy. Molecules. 2023 Jul 24;28(14):5598. doi: 10.3390/molecules28145598. Molecules. 2023. PMID: 37513470 Free PMC article.

Clinical assessment of levamlodipine besylate combination therapy for essential hypertension: A protocol for systematic review and meta-analysis.

Dai GY, Zhu YH. Dai GY, et al. Medicine (Baltimore). 2022 Apr 1;101(13):e29148. doi: 10.1097/MD.0000000000029148. Medicine (Baltimore). 2022. PMID: 35421067 Free PMC article.

Design and evaluation of an HSP70-targeting PROTAC in synergy with an HSF1 inhibitor for enhanced antitumor activity.

Huang WH, Mao TY, Dai GY, Ye JM, Li JB, Chen SB, Tan JH, Huang ZS, Huang SL. Huang WH, et al. Among authors: dai gy. RSC Med Chem. 2025 Nov 18;17(1):385-95. doi: 10.1039/d5md00726g. Online ahead of print. RSC Med Chem. 2025. PMID: 41262768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year